What is the current stock price of NanoVibronix, Inc. (NAOV)?

As of the latest market data, NanoVibronix, Inc. (NAOV) is trading at $1.90. The stock has seen a gain of 1.06% today.

Does NanoVibronix, Inc. (NAOV) pay a dividend?

Based on current data, NanoVibronix, Inc. does not have a confirmed active dividend policy.

What is the market cap of NanoVibronix, Inc.?

The current market capitalization of NanoVibronix, Inc. (NAOV) is approximately unavailable.

NAOV

NanoVibronix, Inc.·Healthcare

1.90

1.064%(+0.02)

Market Closed

4.20

121.053%(+2.30)

After Hours

Last Updated: — ET

52W L: $1.0552W H: $162.50

NAOV NEWS

globenewswire.com

Feb 24

ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera

Technology supports the evolution of enteral access from blind procedures to real-time visualized placement Technology supports the evolution of enteral access from blind procedures to real-time visualized placement

globenewswire.com

Jan 21

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth

Company Profile

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2015-05-28

Beta

2.06

Websitewww.nanovibronix.com↗